Drugs / Dimethane sulfonate
Dimethane sulfonate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00923520 | Mar 2009 → May 2016 | breast cancer, colon carcinoma, lung cancer, non-Hodgkin lymphoma +1 | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dimethane sulfonate | “Dimethane sulfonate (DMS612) is an investigational drug” NCT00923520 ↗ |
| Known as | DMS612 | “Dimethane sulfonate (DMS612) is an investigational drug” NCT00923520 ↗ |
| Known as | NSC 281612 | “dimethane sulfonate (DMS612, NSC 281612) when administered by intravenous (IV) bolus” NCT00923520 ↗ |
| Route | Intravenous | “by intravenous infusion” NCT00923520 ↗ |